Innovation Zed has announced that it has secured a CE Mark for its InsulCheck DOSE add-on device.
InsulCheck DOSE is a single-unit add-on device compatible with all pen injectors that automatically captures the dose value dialled, the time of the injection, the temperature and other data. This is logged and sent automatically to a compatible display device.
Dr Dean Minnock, CEO of Innovation Zed, said, “InsulCheck DOSE provides data that, when applied correctly, facilitates an evidence-driven approach to precision insulin management and significantly helps people with diabetes make more informed choices for their personal therapy plan. Our InsulCheck DOSE supports all insulin pens without changing the usability of the pen in any way and without interfering in the normal injection process. In securing the CE mark for InsulCheck DOSE we reached an incredible milestone for our company and for people living with diabetes in Europe.”
Innovation Zed expects to initiate a commercial launch of InsulCheck DOSE in Europe during 2023. The company also has plans to introduce bespoke variations of InsulCheck DOSE to new injection devices for various drug therapies over the coming years.
To read more, CLICK HERE